Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.3022
+0.0052 (1.75%)
At close: Nov 11, 2026, 4:00 PM EST
0.3022
0.00 (0.00%)
After-hours: Nov 11, 2026, 4:10 PM EST
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $16.62 million as of November 11, 2026. It is the 38,156th most valuable company in the world and the 5,268th biggest in the United States. Its market cap has decreased by 87.71% in one year.
Market Cap
16.62M
Enterprise Value
12.20M
1-Year Change
-87.71%
Global Rank
Country Rank
#5,268 United States
Category
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $16.62M, a decrease of -89.07%. That is a compound annual growth rate of -62.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 16.62M | -88.32% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 17.37M |
| Aligos Therapeutics | 17.23M |
| BioVie | 17.17M |
| Quantum BioPharma | 17.11M |
| Akari Therapeutics, | 17.00M |
| Acumen Pharmaceuticals | 16.85M |
| Jasper Therapeutics | 16.28M |
| Bolt Biotherapeutics | 16.24M |